Partnering_CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD
    <q id="ceecf"></q>
  • <noframes id="ceecf">

        1. <figure id="ceecf"></figure>
          PARTNERING
          PARTNERING We are looking forward to establishing solid collaboration with partners around the world.

          Partnering with us

          We believe that partnerships are the key to sustainable growth and success, and prepare to share the following advantages with partner:


          Highest reputation & awards in China, strong R&D for API and FDF, patent regulation, cost effectiveness, high compliance standards, state-of-art facilities, most advanced machinery and equipment, and vertical integration.


          Research collaboration
          API supply, especially for product with high entry barrier
          Out-licensing
          Technology transfer
          Co-development for API or FDF
          CMO production

          Featured case studies

          • Johnson & Johnson<br> and CTTQ Pharmaceutical Group:
            Johnson & Johnson
            and CTTQ Pharmaceutical Group:
            Entered into a license agreement for development and commercialization of one innovative drug for curative treatment of Hepatitis B.
          • Bio Line<br> Rx and CTTQ Pharmaceutical Group:
            Bio Line
            Rx and CTTQ Pharmaceutical Group:
            Entered into an agreement for co-development and commercialization of an oral drug (BL-8030) for curative treatment of Hepatitis C.

          5000彩票 |5000彩票下载软件 |5000彩票app | |手机版 | | 5000彩票|5000彩票|5000彩票|5000彩票|极速pk10|极速pk10|